Collections: Health Policy and Services Research / Subjects: Government Regulation - Digital Collections - National Library of Medicine Search Results

Start Over Collections Health Policy and Services Research ✖ Subjects Government Regulation ✖ Publication Year 2023 ✖

31. Public health preparedness: Critical need to address deficiencies in HHS’s leadership and coordination of emergencies : testimony before the Subcommittee on Health, Committee on Energy and Commerce, House of Representatives

Publication:: Washington, DC : United States Government Accountability Office, May 11, 2023
Subject(s):: Civil Defense -- organization & administration
Government Regulation
United States
United States. Department of Health and Human Services

32. Veterans health care: Staffing challenges and recommendations for improvement : testimony before the Subcommittee on Health and Subcommittee on Oversight and Investigations, Committee on Veterans' Affairs, House of Representatives

Publication:: Washington, DC : United States Government Accountability Office, May 17, 2023
Subject(s):: Community Health Services -- supply & distribution
Government Regulation
Health Workforce -- legislation & jurisprudence
Legislation, Medical
Mental Health Services -- supply & distribution
Veterans Health Services -- legislation & jurisprudence
Veterans Health Services -- organization & administration
United States
United States. Department of Veterans Affairs

33. Collaborative agreements in health care: complexities, uncertainties, and considerations for oversight

Author(s):: Gu, Amy Y., author
Gudiksen, Katherine L., author
Publication:: [Oakland, CA] : California Health Care Foundation, May 2023
Subject(s):: Facility Regulation and Control
Government Regulation
Intersectoral Collaboration
California

34. Adjusting for covariates in randomized clinical trials for drugs and biological products: guidance for industry

Publication:: Silver Spring, MD : Center for Drug Evaluation and Research, May 2023
Subject(s):: Biological Products
Drug Industry
Government Regulation
Pharmaceutical Preparations
Randomized Controlled Trials as Topic
United States

35. Testing of glycerin, propylene glycol, maltitol solution, hydrogenated starch hydrolysate, sorbitol solution, and other high-risk drug components for diethylene glycol and ethylene glycol: guidance for industry

Publication:: Silver Spring, MD : Center for Drug Evaluation and Research, May 2023
Subject(s):: Drug Contamination
Drug Industry
Drug-Related Side Effects and Adverse Reactions
Ethylene Glycols
Glycerol
Government Regulation
Propylene Glycol
Sorbitol
United States

36. Q9(R1): : quality risk management : guidance for industry

Publication:: Silver Spring, MD : Center for Drug Evaluation and Research, May 2023
Subject(s):: Drug Development
Drug Industry
Government Regulation
Risk Management
United States

37. Smoking cessation and related indications: developing nicotine replacement therapy drug products : guidance for industry

Publication:: Silver Spring, MD : Center for Drug Evaluation and Research, May 2023
Subject(s):: Drug Development
Government Regulation
Nicotine Chewing Gum
Smoking Cessation
Smoking Cessation Agents
Tobacco Use Cessation Devices
United States

38. S12 nonclinical biodistribution considerations for gene therapy products: guidance for industry

Publication:: Silver Spring, MD : Center for Drug Evaluation and Research, May 2023
Subject(s):: Genetic Therapy
Government Regulation
Research Design
United States

39. Peripheral percutaneous transluminal angioplasty (PTA) and specialty catheters: premarket notification (510(k)) submissions : guidance for industry and Food and Drug Administration staff

Publication:: [Silver Spring, MD] : Center for Devices and Radiological Health, April 14, 2023
Subject(s):: Angioplasty, Balloon, Coronary
Cardiac Catheters
Device Approval
Government Regulation
United States

40. A risk-based approach to monitoring of clinical investigations questions and answers: guidance for industry

Publication:: Silver Spring, MD : Center for Drug Evaluation and Research, April 2023
Subject(s):: Clinical Trials Data Monitoring Committees
Clinical Trials as Topic
Government Regulation
Research Design
Research Personnel
United States

« Previous
Next »
1
2
3
4
5
6
7
8
…
19
20